Archive - August 2021
New joint venture aims to ‘open’ funding opportunities for early medicines discovery
bluebird bio re-evaluates gene therapy strategy in ‘untenable’ European market
MHRA nod for Janssen’s relapsing multiple sclerosis drug Ponvory
Pharma’s shift towards a circular economy
Milestone launches
Gene therapy company bluebird bio quits Europe
Positive trials results showing a significant improvement in survival boost Roche’s Polivy
Santen and Sydnexis partner on childhood myopia treatment SYD-101